Fanatics Expands Merchandise Deal With Premier League's Chelsea
As part of the new long-term arrangement set to be announced on Tuesday, Fanatics is obtaining design and manufacturing rights to develop new fan gear for Chelsea. The new deal gives the sports merchandiser a lasting foothold in the world's most-watched domestic soccer league.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Report – Inter Milan Not Interested In Juventus Outcast Or Man United Striker
Inter Milan are reportedly not interested in either Douglas Luiz or Joshua Zirkzee despite talks with their agent. This according to today's print edition of Milan-based newspaper Corriere della Sera, via FCInterNews. Inter Milan held a number of meetings with agents and intermediaries yesterday. It was a busy day with the transfer window now right at its peak. And according to the Corriere della Sera, one of the agents at the Nerazzurri's headquarters was Giuliano Bertolucci. Inter Not Interested In Douglas Luiz Or Joshua Zirkzee NEWCASTLE UPON TYNE, ENGLAND – APRIL 13: Joshua Zirkzee of Manchester United reacts during the Premier League match between Newcastle United FC and Manchester United FC at St James' Park on April 13, 2025 in Newcastle upon Tyne, England. (Photo by) Agent Bertolucci represents a couple of notable players. Therefore, rumours emerged that these could be targets for Inter, or at least names that came up in talks yesterday. One would be that of Douglas Luiz. The Brazilian former Aston Villa and Girona midfielder looks to clearly have one foot out the door at Juventus. Therefore, Inter could represent an exit route for Luiz. However, according to the Corriere della Sera, the Nerazzurri expressed no interest in the 27-year-old. Similarly, there have been plenty of transfer links in the past between Inter and Manchester United striker Joshua Zirkzee. However, despite Bertolucci representing Zirkzee, the Corriere della Sera report that Inter did not show any interest in the Netherlands international in talks yesteday. Rather, the newspaper anticipate, the main purpose of the meeting was to discuss Inter's interest in some young prospects from Brazilian football.
Forbes
19 minutes ago
- Forbes
Centene Reports $253 Million Loss Amid Health Insurer Cost Struggles
Centene chief executive officer Sarah London on Friday July 25, 2025 said the company is ... More "disappointed by our second quarter results, but we have a clear understanding of the trends that have impacted our performance, and are working with urgency and focus to restore our earnings trajectory." In this photo, London speaks during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Photographer: Michael Nagle/Bloomberg Health insurer Centene reported a $253 million loss in its second quarter as the provider of government-subsidized benefits struggles to manage costs of its health plan members. The $253 million loss, or 51 cents a share, compares to a $1.1 billion in net income, or $2.16 a share, in the second quarter of last year, Centene disclosed Friday in its quarterly earnings report. Centene said premium and service revenues increased 18% to $42.5 billion from $36 billion in the year ago period. Centene, which has 28 million health plan subscribers, is seeing rising costs among health plan members in all three government-subsidized benefits it helps manage: Medicaid, Medicare Advantage and individual coverage under the Affordable Care Act, also known as Obamacare. "We are disappointed by our second quarter results, but we have a clear understanding of the trends that have impacted our performance and are working with urgency and focus to restore our earnings trajectory," Centene Chief Executive Officer Sarah M. London said in a statement accompanying the company's earnings report. "Despite the shifting landscape, we believe that the staying power of Medicaid, Medicare and the Individual Marketplace is as strong as it has ever been. Centene has significantly fortified our platform in service of these programs over the last three years, and as we move forward, we are focused on continuing to adapt with the market to deliver meaningful value to our members, our stakeholders and our shareholders over the long term." Centene, which planned to reveal its 2025 profit forecast during a call with analysts Friday morning, pulled its financial guidance earlier this month, citing an independent firm's analysis showing patients it provides health benefits for were sicker and needed more healthcare services than anticipated. On Friday, Centene said its health benefits ratio, which is the percentage of premium revenue that goes toward medical costs, jumped to 93% for the second quarter of 2025, compared to 87.6% in the comparable period in 2024. 'The (health benefits ratio) increase was primarily driven by a reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, increased Marketplace medical costs, higher medical costs in Medicaid driven primarily by behavioral health, home health and high-cost drugs, and an increase to the 2025 Medicare Advantage premium deficiency reserve based on the progression of earnings during the year (with higher earnings at the beginning of the year and lower at the end of the year, given cost sharing progression),' Centene said in its second quarter earnings report. Centene's cost struggles are only the latest among a parade of health insurance companies that have struggled in the last two years to control costs of subscribers in plans subsidized by the government. Just last week, Elevance Health, which sells Blue Cross and Blue Shield plans in 14 states, lower its profit forecast for the rest of 2025 due to rising costs in its Medicaid plans and individual policies it sells under the Affordable Care Act. In addition, Molina Healthcare lowered its earnings guidance for the rest of the year in the face of cost pressures in all three of the government-subsidized health insurance programs it helps manage: Medicaid, Medicare Advantage and individual coverage under the ACA, also known as Obamacare. And in May, UnitedHealth suspended its financial outlook for the rest of the year and replaced its top executive as the parent of UnitedHealthcare grapples with rising healthcare costs in its Medicare Advantage business. Medicare Advantage plans contract with the federal government to provide health benefits to seniors. Medicare Advantage plans also contributed to struggles last year for Humana and CVS Health, which elevated a new chief executive in part to help gain control of its struggling Aetna health insurance business. CVS is also exiting the individual health insurance business, leaving about 1 million Aetna members in 17 states looking for new coverage in 2026.
New York Times
19 minutes ago
- New York Times
Leeds make offer worth more than €30m for Feyenoord winger Igor Paixao
Leeds United have tabled a bid worth in excess of €30million for Feyenoord winger Igor Paixao. Talks between Leeds, Feyenoord and Paixao's representatives have been ongoing since last week. Marseille have shown the greatest interest in signing the 25-year-old to this point but the Ligue 1 outfit, who are bound for next season's Champions League, have so far failed to bring their negotiations with the Dutch giants over the line. Advertisement Leeds have now made their move for Paixao, with interest driven by sporting director Adam Underwood. A move to Elland Road would offer the Brazilian the chance to play Premier League football and take a similar path to compatriot Raphinha, who is now at Barcelona. Paixao scored 16 goals and provided 10 assists in 34 appearances for the Rotterdam outfit in last season's Eredivisie, as Feyenoord finished third. Meanwhile, the final stages of fellow Brazilian Lucas Perri's transfer to Leeds are progressing in Germany. The goalkeeper arrived at the team's training camp from Lyon on Thursday night, with a medical expected to take place on Friday. The final fee for that move is expected to be worth €16million (£13.9m, $18.8m) plus €2million (£1.7m, $2.4m) in add-ons.
